CDH13 and ovarian carcinoma: A group of miRNAs (miR-181d, miR-30a-3p, miR-30c, miR-30d, miR-30e-3p, miR-370, miR-493-5p, and miR-532-5p) has been associated with ovarian carcinoma progression and predicted to target CDH13.